LIVETRADES Interviews today’s top pro traders and analysts.

LiveTrades.TV Featuring  @StockReversals & @WeeklyTrade / Is #AR Leader Vuzix $VUZI Ready for Breakout?
November 21
Trader & Analyst Interviews

is episode of LIVETRADES.TV we're joined by veteran trader, Anthony Verdone who will be interviewing the Chief Strategist & Founder of StockReversals.com. Dave is a professional equities trader who's strategies include Swing Trades with a twist, mastering market movements in advance, saving research time, reducing risks, and increasing your profitability.

LiveTrades.TV Weekly Picks: Vuzix $VUZI – Leader in AR Smart Glasses
November 20
Trader & Analyst Interviews

In this episode of the LiveTrades.TV's, we’re joined by veteran trader, Anthony Verdone to discuss Vuzix, a leading supplier of Smart Glasses, Augmented Reality technologies and products for the consumer and enterprise markets which trades under ticker VUZI.

Citius Pharma $CTXR May Be Ready for Further Breakout to the Upside
November 08
Trader & Analyst Interviews

In this episode of LiveTrades.TV, we are joined by veteran trader Anthony Verdone (@weeklytrade) to discuss Citius Pharmaceuticals, ticker CTXR. Citius is a specialty pharmaceutical company dedicated to the development and commercialization of unique therapeutic products in adjunctive cancer care with a focus on infectious diseases.

Top traders and investors offer their opinions and analysis of markets, sectors and favorite stocks.

Trading Insights: Possible Trade Setting Up In CTXR
November 09
Trading Insights & NewsUncategorized

Today we are going to take a technical look at Citius Pharmaceuticals, Inc. They are a Specialty Pharmaceutical company that has recently received some good news from the FDA regarding their lead product, Mino-Lok(TM), a device that has exhibited effectiveness in trials for treatment of catheter related bloodstream infections. On October 31 the company received fast track status for its product and is now in phase 3 trials.

Citius Pharma $CTXR in Prime Position to Capitalize on a Potential $750 Million Sector with Mino-Lok Therapy
November 07
Trading Insights & News

Citius Pharmaceuticals (NASDAQ: CTXR) is a specialty pharmaceutical company dedicated to the development and commercialization of therapeutic products for large and growing markets. Citius is currently advancing two proprietary product candidates, Mino-Lok™, and a hydrocortisone-lidocaine formulation.

BioSig Technologies $BSGM Innovative Platform Has Huge Potential in Electrophysiology Market
November 01
Trading Insights & News

BioSig Technologies, Inc., a development stage medical device company, engages in developing a proprietary technology platform to minimize noise and artifacts from cardiac recordings during electrophysiology studies and ablation.

LIVETRADES interviews innovative, up and coming small cap companies

Financial Gravity $FGCO Offers Attractive Growth Opportunity in Tax Planning Services
November 20
Company Interviews

Financial Gravity provides sophisticated tax planning for small to medium sized businesses helping them save thousands of dollars annually on their tax bill. Mr. Pollock discusses the size of the demand for tax planning services in this market and why has it been so neglected by the financial services industry with regards to better tax planning.

Vuzix $VUZI Taking Augmented Reality By Storm with Award Winning Smart Glasses Technology
November 16
Company Interviews

We are back again with Vuzix, a leading supplier of Smart Glasses, Augmented Reality technologies and products for the consumer and enterprise markets which trades under ticker VUZI.

Login

Lost your password?